Market Cap 73.27M
Revenue (ttm) 56.65M
Net Income (ttm) -53.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -94.10%
Debt to Equity Ratio 2.94
Volume 639,000
Avg Vol 758,854
Day's Range N/A - N/A
Shares Out 26.64M
Stochastic %K 14%
Beta 0.81
Analysts Sell
Price Target $5.90

Company Profile

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular sy...

Industry: Medical Devices
Sector: Healthcare
Phone: 763 416 2840
Fax: 763 416 2841
Address:
9201 West Broadway Avenue, Suite 650, Minneapolis, United States
Weston1989
Weston1989 Aug. 18 at 1:58 PM
$CVRX Finally some greeen..
0 · Reply
focafoca99
focafoca99 Aug. 18 at 1:32 PM
$CVRX warns investors of securities-fraud investigation by Block & Leviton.
0 · Reply
Stock_Whale
Stock_Whale Aug. 18 at 1:41 AM
$CVRX these guys are going to need to dilute. Their cash burn is way too high, too much debt for an unprofitable small medical device company. Lowering guidance on sales is a huge problem and blaming your sales team on the last 2 earnings calls is not who you want to invest your money with. Good product terrible management.
0 · Reply
Twister8
Twister8 Aug. 17 at 11:33 PM
$CVRX the COO is a bag holder, follow JNJ
0 · Reply
MITornado
MITornado Aug. 17 at 6:45 PM
$CVRX can buy cheaper than the COO….seems like a deal.
1 · Reply
Twister8
Twister8 Aug. 17 at 6:18 PM
$CVRX What is JNJ doing?
0 · Reply
Dylberts
Dylberts Aug. 17 at 1:46 PM
$CVRX these are great prices, some evaluations are low, but even at a modest $5 evaluation (for now) that's a big return!
0 · Reply
LordWorld
LordWorld Aug. 14 at 11:22 PM
$CVRX Investor Chernett Jorey reported owning 5.5% of CVRX shares, although in his disclosure, he stated that he would not influence management actions but could change this at any time. Jorey is known for always setting his own terms whenever he makes a deal, and in most cases, he always insisted on selling the entire company.
0 · Reply
FeliciaMath
FeliciaMath Aug. 14 at 6:09 PM
bought $CVRX at 3.13
0 · Reply
LordWorld
LordWorld Aug. 14 at 4:09 PM
0 · Reply
Latest News on CVRX
CVRx chief revenue officer Robert John to depart

2026-08-11T11:35:50.000Z - 8 days ago

CVRx chief revenue officer Robert John to depart


CVRx downgraded to Hold from Buy at Lake Street

2026-08-07T12:11:51.000Z - 12 days ago

CVRx downgraded to Hold from Buy at Lake Street


CVRx downgraded to Hold from Buy at Craig-Hallum

2026-08-07T11:31:09.000Z - 12 days ago

CVRx downgraded to Hold from Buy at Craig-Hallum


CVRx price target lowered to $5 from $10 at Canaccord

2026-08-07T11:27:07.000Z - 12 days ago

CVRx price target lowered to $5 from $10 at Canaccord


CVRx downgraded to Neutral from Overweight at Piper Sandler

2026-08-07T08:45:31.000Z - 12 days ago

CVRx downgraded to Neutral from Overweight at Piper Sandler


CVRx, Inc. Earnings Call Transcript: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

CVRx, Inc. Earnings Call Transcript: Q2 2026


CVRx, Inc. Earnings release: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

CVRx, Inc. Earnings release: Q2 2026


CVRx, Inc. Quarterly report: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

CVRx, Inc. Quarterly report: Q2 2026


CVRx CFO Jared Oasheim to step down

2026-06-09T11:41:42.000Z - 2 months ago

CVRx CFO Jared Oasheim to step down


CVRx Announces Chief Financial Officer Transition

Jun 9, 2026, 7:30 AM EDT - 2 months ago

CVRx Announces Chief Financial Officer Transition


CVRx, Inc. Transcript: AGM 2026

Jun 1, 2026, 11:00 AM EDT - 2 months ago

CVRx, Inc. Transcript: AGM 2026


CVRx, Inc. Earnings Call Transcript: Q1 2026

May 11, 2026, 4:30 PM EDT - 3 months ago

CVRx, Inc. Earnings Call Transcript: Q1 2026


CVRx, Inc. Earnings release: Q1 2026

May 11, 2026, 4:30 PM EDT - 3 months ago

CVRx, Inc. Earnings release: Q1 2026


CVRx, Inc. Quarterly report: Q1 2026

May 11, 2026, 4:30 PM EDT - 3 months ago

CVRx, Inc. Quarterly report: Q1 2026


CVRx Reports First Quarter 2026 Financial and Operating Results

May 11, 2026, 4:05 PM EDT - 3 months ago

CVRx Reports First Quarter 2026 Financial and Operating Results


CVRx enrolls first patient in BENEFIT-HF trial

2026-05-04T21:15:14.000Z - 3 months ago

CVRx enrolls first patient in BENEFIT-HF trial


CVRx, Inc. Proxy statement: Proxy filing

Apr 20, 2026, 8:00 AM EDT - 4 months ago

CVRx, Inc. Proxy statement: Proxy filing


CVRx, Inc. Proxy statement: Proxy filing

Apr 20, 2026, 8:00 AM EDT - 4 months ago

CVRx, Inc. Proxy statement: Proxy filing


CVRx, Inc. Investigated by the Portnoy Law Firm

Apr 9, 2026, 9:00 AM EDT - 4 months ago

CVRx, Inc. Investigated by the Portnoy Law Firm


CVRx price target lowered to $6 from $7 at JPMorgan

2026-02-13T12:10:44.000Z - 6 months ago

CVRx price target lowered to $6 from $7 at JPMorgan


CVRx price target lowered to $10 from $11 at Canaccord

2026-02-13T11:55:30.000Z - 6 months ago

CVRx price target lowered to $10 from $11 at Canaccord


CVRx, Inc. Earnings Call Transcript: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

CVRx, Inc. Earnings Call Transcript: Q4 2025


CVRx, Inc. Annual report: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

CVRx, Inc. Annual report: Q4 2025


CVRx, Inc. Earnings release: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

CVRx, Inc. Earnings release: Q4 2025


CVRx, Inc. Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:45 PM EST - 7 months ago

CVRx, Inc. Slides: 44th Annual J.P. Morgan Healthcare Conference


CVRx, Inc. Slides: FY 2025

Nov 18, 2025, 3:00 AM EST - 9 months ago

CVRx, Inc. Slides: FY 2025


CVRx, Inc. Registration statement: Registration Filing

Nov 6, 2025, 7:00 AM EST - 10 months ago

CVRx, Inc. Registration statement: Registration Filing


CVRx, Inc. Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

CVRx, Inc. Earnings Call Transcript: Q3 2025


CVRx, Inc. Quarterly report: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

CVRx, Inc. Quarterly report: Q3 2025


CVRx, Inc. Earnings release: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

CVRx, Inc. Earnings release: Q3 2025


CVRx, Inc. Earnings Call Transcript: Q2 2025

Aug 4, 2025, 4:30 PM EDT - 1 year ago

CVRx, Inc. Earnings Call Transcript: Q2 2025


CVRx, Inc. Quarterly report: Q2 2025

Aug 4, 2025, 4:30 PM EDT - 1 year ago

CVRx, Inc. Quarterly report: Q2 2025


CVRx, Inc. Earnings release: Q2 2025

Aug 4, 2025, 4:30 PM EDT - 1 year ago

CVRx, Inc. Earnings release: Q2 2025


CVRx, Inc. Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

CVRx, Inc. Earnings Call Transcript: Q1 2025


CVRx, Inc. Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

CVRx, Inc. Quarterly report: Q1 2025


CVRx, Inc. Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

CVRx, Inc. Earnings release: Q1 2025


CVRx, Inc. Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

CVRx, Inc. Proxy statement: Proxy Filing


CVRx, Inc. Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

CVRx, Inc. Proxy statement: Proxy Filing


CVRx, Inc. Earnings Call Transcript: Q4 2024

Feb 4, 2025, 4:30 PM EST - 1 year ago

CVRx, Inc. Earnings Call Transcript: Q4 2024


CVRx, Inc. Annual report: Q4 2024

Feb 4, 2025, 4:30 PM EST - 1 year ago

CVRx, Inc. Annual report: Q4 2024


CVRx, Inc. Earnings release: Q4 2024

Feb 4, 2025, 4:30 PM EST - 1 year ago

CVRx, Inc. Earnings release: Q4 2024


CVRx, Inc. Slides: FY 2025

Jan 15, 2025, 5:15 PM EST - 1 year ago

CVRx, Inc. Slides: FY 2025


CVRx, Inc. Earnings Call Transcript: Q3 2024

Oct 29, 2024, 4:30 PM EDT - 1 year ago

CVRx, Inc. Earnings Call Transcript: Q3 2024


CVRx, Inc. Quarterly report: Q3 2024

Oct 29, 2024, 4:30 PM EDT - 1 year ago

CVRx, Inc. Quarterly report: Q3 2024


CVRx, Inc. Earnings release: Q3 2024

Oct 29, 2024, 4:30 PM EDT - 1 year ago

CVRx, Inc. Earnings release: Q3 2024


CVRx announces new CPT® Category I codes for Barostim

Oct 18, 2024, 2:08 PM EDT - 1 year ago

CVRx announces new CPT® Category I codes for Barostim


CVRx Announces Appointment of Two New Board Members

Sep 3, 2024, 8:30 AM EDT - 2 years ago

CVRx Announces Appointment of Two New Board Members


Weston1989
Weston1989 Aug. 18 at 1:58 PM
$CVRX Finally some greeen..
0 · Reply
focafoca99
focafoca99 Aug. 18 at 1:32 PM
$CVRX warns investors of securities-fraud investigation by Block & Leviton.
0 · Reply
Stock_Whale
Stock_Whale Aug. 18 at 1:41 AM
$CVRX these guys are going to need to dilute. Their cash burn is way too high, too much debt for an unprofitable small medical device company. Lowering guidance on sales is a huge problem and blaming your sales team on the last 2 earnings calls is not who you want to invest your money with. Good product terrible management.
0 · Reply
Twister8
Twister8 Aug. 17 at 11:33 PM
$CVRX the COO is a bag holder, follow JNJ
0 · Reply
MITornado
MITornado Aug. 17 at 6:45 PM
$CVRX can buy cheaper than the COO….seems like a deal.
1 · Reply
Twister8
Twister8 Aug. 17 at 6:18 PM
$CVRX What is JNJ doing?
0 · Reply
Dylberts
Dylberts Aug. 17 at 1:46 PM
$CVRX these are great prices, some evaluations are low, but even at a modest $5 evaluation (for now) that's a big return!
0 · Reply
LordWorld
LordWorld Aug. 14 at 11:22 PM
$CVRX Investor Chernett Jorey reported owning 5.5% of CVRX shares, although in his disclosure, he stated that he would not influence management actions but could change this at any time. Jorey is known for always setting his own terms whenever he makes a deal, and in most cases, he always insisted on selling the entire company.
0 · Reply
FeliciaMath
FeliciaMath Aug. 14 at 6:09 PM
bought $CVRX at 3.13
0 · Reply
LordWorld
LordWorld Aug. 14 at 4:09 PM
0 · Reply
yousef112
yousef112 Aug. 14 at 9:14 AM
0 · Reply
Rounderssss4
Rounderssss4 Aug. 14 at 8:55 AM
$CVRX well hello 3s
0 · Reply
AlertsAndNews
AlertsAndNews Aug. 14 at 3:12 AM
$CVRX CVRx: Brent Binkowski (Chief Operating Officer) Buys 26,223 Shares @ Average Price of $2.91 (Form 4)
0 · Reply
tastysider
tastysider Aug. 14 at 12:24 AM
$CVRX always winning
0 · Reply
Twister8
Twister8 Aug. 13 at 3:51 PM
0 · Reply
Rounderssss4
Rounderssss4 Aug. 13 at 3:42 PM
0 · Reply
Rounderssss4
Rounderssss4 Aug. 13 at 3:37 PM
$CVRX this and $SION completely over kill
0 · Reply
Inphatec
Inphatec Aug. 13 at 3:18 PM
$CVRX 3+ today?
0 · Reply
Rounderssss4
Rounderssss4 Aug. 13 at 2:33 PM
$CVRX Beautiful bounce off the bottom earlier this week.
1 · Reply
flychicken1991
flychicken1991 Aug. 13 at 7:21 AM
$CVRX Mixed (78%): shares could gain if broader payer coverage raises expected Barostim utilization and revenue, but sales-force strain and uncertainty around converting coverage into procedures could pressure the stock by limiting near-term estimate upgrades and... Full AI impact map, source, and watch-next details: https://nimpact.tech/newsimpact/news/7e1c9879b0e23ee7?utm_source=stocktwits&utm_medium=story_url
0 · Reply
Twister8
Twister8 Aug. 12 at 4:19 PM
$CVRX what is JNJ doing with their shares?
0 · Reply
Inphatec
Inphatec Aug. 12 at 3:53 PM
@SteveStachion Thoughts on $CVRX
1 · Reply